RBS-001

· Rophibio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RBS-001, covering 2025-04-06 to 2025-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration [Phase 3]

See pricing